Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Acceptability of Telehealth Triage Using Robotic Systems in COVID-19

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04452695
Recruitment Status : Recruiting
First Posted : June 30, 2020
Last Update Posted : July 31, 2020
Sponsor:
Information provided by (Responsible Party):
Peter R Chai, Brigham and Women's Hospital

Brief Summary:
The overall objective of this investigation is to understand the patient response to a robotic platform used to facilitate telehealth triage in the emergency department during the COVID-19 pandemic. The COVID-19 pandemic has altered the manner in which emergency department triage is completed. Attempts at cohorting individuals with potential COVID-19 disease in order to prevent disease transmission to healthcare workers and minimize the use of personal protective equipment (PPE) have renewed interest in telemedical solutions as a method to triage and manage individuals with COVID-19. This investigation deploys a legged robotic platform to facilitate agile, highly mobile telemedicine to manage COVID-19 patients in the emergency department. The primary objective is to measure the patient response to interacting with these systems.

Condition or disease Intervention/treatment
COVID-19 Telemedicine Robotics Emergencies Emerging Infectious Disease Device: Doctor Spot

Layout table for study information
Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Acceptability of Telehealth Triage Using Robotic Systems in COVID-19
Actual Study Start Date : March 10, 2020
Estimated Primary Completion Date : July 31, 2020
Estimated Study Completion Date : July 31, 2020

Group/Cohort Intervention/treatment
Intervention arm
Patients presenting to the emergency department are triaged using a novel robotic telehealth triage system. Once triage is complete, patients complete a quantitative assessment to measure their acceptance and willingness to interact with the robotic telehealth system.
Device: Doctor Spot
Robotic platform (Boston Dynamics) controlled by clinician with video interface to facilitate telemedicine triage




Primary Outcome Measures :
  1. Acceptance of robotic telehealth system [ Time Frame: Immediately after completion of triage ]
    Quantitative questionnaire on the acceptance of virtual robotic care graded on a likert scale (higher scores better)

  2. Willingness to interact with robotic telehealth system [ Time Frame: Immediately after completion of triage ]
    Quantitative questionnaire on the willingness to use this system again based on a likert scale (higher scores better)

  3. Satisfaction of interacting with a robotic telehealth system [ Time Frame: Immediately after completion of triage ]
    Quantitative questionnaire on the user satisfaction with their triage experience (How satisfied were you with your experience interacting with the robotic system today?)


Secondary Outcome Measures :
  1. Use of robotic system versus in-person triage [ Time Frame: Immediately after completion of triage ]
    Quantitative questionnaire comparing robotic triage process with in-person triage: Do you think your interaction with the robotic system was better, the same or no different than an in-person evaluation?)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Emergency department patients
Criteria

Inclusion Criteria:

  • Presenting to the emergency department for evaluation
  • > 18 years old

Exclusion Criteria:

  • Brought to emergency department via ambulance
  • <18 years old
  • non-english speaking
  • in extremis, or unable to participate due to underlying acute medical condition

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04452695


Contacts
Layout table for location contacts
Contact: Peter R Chai, MD MMS 617-732-5640 pchai@bwh.harvard.edu
Contact: Carlo G Traverso, MD PhD ctraverso@bwh.harvard.edu

Locations
Layout table for location information
United States, Massachusetts
Brigham and Women's Hospital Recruiting
Boston, Massachusetts, United States, 02115
Contact: Peter R Chai, MD MMS    617-732-5640    pchai@bwh.harvard.edu   
Contact: Carlo G Traverso, MD PhD       ctraverso@bwh.harvard.edu   
Sponsors and Collaborators
Brigham and Women's Hospital
Layout table for additonal information
Responsible Party: Peter R Chai, Assistant Professor, Brigham and Women's Hospital
ClinicalTrials.gov Identifier: NCT04452695    
Other Study ID Numbers: 2020P000957
First Posted: June 30, 2020    Key Record Dates
Last Update Posted: July 31, 2020
Last Verified: July 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Communicable Diseases
Infection
Communicable Diseases, Emerging
Emergencies
Disease Attributes
Pathologic Processes